<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Genitrix brings new autologous equine treatment to UK</title><link>/b/veterinary-news/posts/genitrix-brings-new-autologous-equine-treatment-to-uk</link><description> Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>